ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

4 links0 made here, not in the record7 judgments2 judges (our rules as one)0 record changes seen
Claude Opus 5.5Our rules
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT03713593Safety and Efficacy ofLenvatinib (E7080/MK-7902)in Combination WithPembrolizumab (MK-3475)Versus Lenvatinib asFirst-line Therapy inParticipants With AdvancedMerck Sharp & Dohme LLCPhase 3 · completedRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSCarcinoma, HepatocellularThe registry's MeSH filing›Nov 14 · Our condition-kind rule · Finest filed termAs of now · Our main-condition rule (R9) · Main conditionMain conditionParkinson Disease 4, Autoso…The registry's MeSH filing›Nov 14 · Our condition-kind rule · MisfiledMisfiledDRUGSLenvatinibIntervention entry›Nov 2 · Claude Opus 5.5 · Background · establishedNov 18 · Our role rule · BackgroundBackground · establishedPembrolizumabIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Our role rule · TestedTested

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Lenvatinib

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “lenvatinib”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Background · established
Background · established · 2

All judgments on this study

WhenLinkJudgeDecisionState
Nov 2LenvatinibClaude Opus 5.5Background · establishedCurrent
Nov 2PembrolizumabClaude Opus 5.5TestedCurrent
Nov 14Carcinoma, HepatocellularOur condition-kind ruleFinest filed termCurrent
Nov 14Parkinson Disease 4, Autosomal Dominant Lewy BodyOur condition-kind ruleMisfiledCurrent
Nov 18LenvatinibOur role ruleBackgroundAgrees
Nov 18PembrolizumabOur role ruleTestedAgrees
As of nowCarcinoma, HepatocellularOur main-condition rule (R9)Main conditionCurrent